Tag Archives: Treatment

FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »

FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer

FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer Print this page April 12, 2019 — The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or… Read More »

Promising treatment for chronic fatigue syndrome fails large trial

iStock / Getty Images Plus By Clare Wilson A medicine that people hoped would treat chronic fatigue syndrome (CFS) has failed its first large placebo-controlled trial. The drug, called rituximab, is used to treat cancer and autoimmune diseases in which the immune system makes antibodies that turn against the body. The medicine works by killing the cells that… Read More »

New Parkinson's treatment could halt and even REVERSE disease symptoms

A new treatment that can halt and even reverse Parkinson’s disease is giving sufferers fresh hope. Researchers found boosting levels of a naturally occurring protein can regenerate dying brain cells – if delivered directly into the brain via tubes. The £3million study, funded by Parkinson’s UK and pharma firm MedGenesis, had a five-year trial at… Read More »

Medical News Today: What to expect from Lupron treatment

Lupron is the brand name for leuprolide acetate. This drug is a type of hormone therapy that doctors typically use in combination with other treatments to treat people with prostate cancer. Lupron belongs to a class of drugs called luteinizing hormone-releasing hormone (LHRH) agonists. These medications block the production of LHRH in the body, which… Read More »